Since CXCR2 may be expressed on cancer cells, endothelial cells, and even immune cells, this signaling axis has the potential to exert protumorigenic effects both within the tumor cells themselves and also within cells of the tumor microenvironment to influence angiogenesis and the immune contexture. Here, CXCR2 is linked to neoplasm.